Recombinant Human CD52 Protein (Gly25-Ser36), C-hFc-tagged
Product Description
Cat
IMP-10341
Official Symbol
CD52
Product Overview
Recombinant human CD52 protein (Gly25-Ser36) with a Human IgG1 (Pro100-Lys330) Fc tag at C-terminus was expressed in Human embryonic kidney cell.
Description
Involved in positive regulation of cytosolic calcium ion concentration. Predicted to be located in extracellular region and plasma membrane. Predicted to be intrinsic component of plasma membrane. Predicted to be active in sperm midpiece.
Expression System
HEK293
Species
Human
Tag
C-hFc
Predicted N Terminal
Gly25
Form
Lyophilized from a 0.2 μm filtered solution in PBS.
Molecular Mass
Predicted Molecular Mass: 28 kDa
SDS-PAGE: 38-44 kDa, reducing conditions
Protein length
Gly25-Ser36
Bio-activity
Measured by its binding ability in a functional ELISA. When Recombinant Human CD52 Fc Chimera is immobilized at 1 μg/mL, 100 μL/well, the concentration of Recombinant Human Siglec-10 Fc Chimera that produces 50% of the optimal binding response is approximately 1-5 μg/mL.
Endotoxin
<0.10 EU/μg of the protein by the LAL method.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Notes
Disulfide-linked homodimer
Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 centigrade as supplied.
1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
Reconstitution
Reconstitute at 200 μg/mL in PBS.
Bioactivity-ELISA 1
Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Human CD52 Fc Chimera is immobilized at 1 μg/mL, 100 μL/well, the concentration of Recombinant Human Siglec-10 Fc Chimera that produces 50% of the optimal binding response is approximately 1-5 μg/mL.

Data Sheet MSDS
For research or industrial raw materials, not for personal medical use!

Online Inquiry
Contact Info